Flagship Pioneering as of June 30, 2023
Portfolio Holdings for Flagship Pioneering
Flagship Pioneering holds 10 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Moderna (MRNA) | 69.9 | $1.6B | 13M | 121.50 | |
| Sana Biotechnology (SANA) | 8.9 | $198M | 33M | 5.96 | |
| Omega Therapeutics (OMGAQ) | 7.3 | $164M | 29M | 5.60 | |
| Seres Therapeutics | 4.9 | $111M | 23M | 4.79 | |
| Foghorn Therapeutics (FHTX) | 4.0 | $89M | 13M | 7.04 | |
| Denali Therapeutics (DNLI) | 3.5 | $77M | 2.6M | 29.51 | |
| Sigilon Therapeutics | 0.8 | $18M | 798k | 22.51 | |
| Evelo Biosciences (EVLO) | 0.4 | $8.2M | 2.5M | 3.25 | |
| Axcella Health Inc equity | 0.3 | $6.4M | 29M | 0.22 | |
| Syros Pharmaceuticals (SYRS) | 0.1 | $3.1M | 994k | 3.15 |
